Harvard Bioscience (HBIO) Gains from Sales and Divestitures (2017 - 2023)
Harvard Bioscience (HBIO) reported Gains from Sales and Divestitures of $316210.0 for Q4 2023, down 21.21% year-over-year from $401308.0 in Q4 2022, and up 172.65% on a QoQ basis from $115976.0 in Q3 2023.
Harvard Bioscience (HBIO) has 7 years of Gains from Sales and Divestitures data on file, last reported at $316210.0 in Q4 2023.
- Quarterly Gains from Sales and Divestitures fell 21.21% year-over-year to $316210.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $316210.0 (down 21.21% YoY) and the FY2023 annual result came in at $316210.0, down 21.21% from the prior year.
- Gains from Sales and Divestitures climbed to $316210.0 in Q4 2023 per HBIO's latest filing, from $115976.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $1.2 million in Q4 2021 and bottomed at $115976.0 in Q2 2023.
- The 5-year median for Gains from Sales and Divestitures is $278207.5 (2020), against an average of $407903.2.
- The widest annual swing landed in 2019, when Gains from Sales and Divestitures jumped 21439.49%; it then tumbled 70.95% in 2022.
- Tracing HBIO's Gains from Sales and Divestitures over 5 years: stood at $813762.0 in 2019, then sank by 70.48% to $240205.0 in 2020, then jumped by 386.03% to $1.2 million in 2021, then sank by 65.63% to $401308.0 in 2022, then declined by 21.21% to $316210.0 in 2023.
- Per Business Quant, the three latest HBIO Gains from Sales and Divestitures figures stand at $316210.0 (Q4 2023), $115976.0 (Q3 2023), and $115976.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 316,210.00 |
| Dec 31, 2023 | 316,210.00 |
| Sep 30, 2023 | 115,976.00 |
| Sep 30, 2023 | 115,976.00 |
| Jun 30, 2023 | 115,976.00 |
| Jun 30, 2023 | 115,976.00 |
| Mar 31, 2023 | 125,036.00 |
| Mar 31, 2023 | 125,036.00 |
| Dec 31, 2022 | 401,308.00 |
| Dec 31, 2022 | 401,308.00 |
| Sep 30, 2022 | 232,157.00 |
| Sep 30, 2022 | 232,157.00 |
| Jun 30, 2022 | 232,157.00 |
| Jun 30, 2022 | 232,157.00 |
| Mar 31, 2022 | 151,185.00 |
| Mar 31, 2022 | 151,185.00 |
| Dec 31, 2021 | 1.17 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 799,264.00 |
| Sep 30, 2021 | 799,264.00 |
| Jun 30, 2021 | 539,417.00 |
| Jun 30, 2021 | 539,417.00 |
| Dec 31, 2020 | 240,205.00 |
| Dec 31, 2020 | 240,205.00 |
| Sep 30, 2020 | 233,056.00 |
| Sep 30, 2020 | 233,056.00 |
| Jun 30, 2020 | 513,779.00 |
| Jun 30, 2020 | 513,779.00 |
| Mar 31, 2020 | 529,491.00 |
| Mar 31, 2020 | 529,491.00 |
| Dec 31, 2019 | 813,762.00 |
| Dec 31, 2019 | 813,762.00 |
| Dec 31, 2018 | 3,778.00 |
| Dec 31, 2018 | 3,778.00 |
| Dec 31, 2017 | 845,326.00 |
| Dec 31, 2017 | 845,326.00 |